Emerging monoclonal antibody therapies in the treatment of metastatic urothelial carcinoma.

Rohit K Jain,Avani M Singh,Xuefeng Wang,José A Guevara-Patiño,Guru Sonpavde

Expert opinion on emerging drugs（2023）

引用 0|浏览21

暂无评分

摘要

Often used in combination with immunotherapy or other therapeutic agents, monoclonal antibody therapies have exhibited efficacy in mUC in early trials. Upcoming clinical trials will further explore their full clinical utility in treating mUC patients.

查看译文

关键词

FGFR,HER-2,KIR-2,Monoclonal antibody therapy,VEG-F,urothelial carcinoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要